Successfully Managing Diabetes in Long-Term
Care With Insulin-Based Regimens:
An Educational Series With Performance Improvement
Program Overview
According to recent survey data, as many as 70% of diabetic patients in long-term care (LTC) settings require insulin. Despite the availability of effective insulin-based regimens, many of these patients are not optimally treated.
This integrated series of on-demand and live educational activities will ensure that all healthcare providers in the LTC setting are able to use practical and effective resources to reduce the barriers to optimal therapy for patients requiring insulin.
To sign-up for this integrated series, including live regional meetings and
on-demand activities, and/or to participate in the outcomes reporting, please click here.
Live Regional Meetings Sign-Up
Part 1 provides a scientific and educational context for the barriers to optimal management of insulin-dependent patients, as well as practical tools for Consultant Pharmacists, Directors of Nursing, and Medical Directors to overcome these barriers.
In Part 2, healthcare professionals can participate in an on-demand expert roundtable that addresses specific challenges in achieving and maintaining glycemic control in the long-term care setting, such as the patient with inadequate control on oral therapy, or patients with comorbid conditions.
Links
Sign-Up
To register for the live regional meetings, on-demand activities, and participate in the outcomes reporting, please sign-up now!
This CME/CNE/CPE activity is jointly sponsored by Purdue University School of Pharmacy, and PVI, PeerView Institute for Medical Education.
This activity is supported by an educational grant from sanofi-aventis U.S.
PVI, PeerView Institute for Medical Education, and Purdue University School of Pharmacy are responsible for the selection of this report's topic, the preparation of editorial content, and the distribution of this report. The preparation of PeerView reports is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Purdue University School of Pharmacy. Our reports may contain references to unapproved products or uses of these products in certain jurisdictions. For approved prescribing information, please consult the manufacturer's product labeling. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in our reports.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its supporters.